Bionomics
(ASX) BNO
Bionomics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$15.66M
Net Income (TTM)
$8.43M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
BNO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bionomics
Industry
Biotechnology
Sector
Health CareEmployees
24
CEO
Spyridon Papapetropoulos, MD, PhD
Website
www.bionomics.com.auHeadquarters
Eastwood, SA 5063, AU
BNO Financials
Key Financial Metrics (TTM)
Gross Margin
96%
Operating Margin
-137%
Net Income Margin
-45%
Return on Equity
-15%
Return on Capital
-33%
Return on Assets
-10%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$434.00K
Operating Income
$17.89B
EBITDA
$9.84M
Operating Cash Flow
$14.68M
Capital Expenditure
$4.44
Free Cash Flow
$14.68M
Cash & ST Invst.
$12.61M
Total Debt
$272.74K
Bionomics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$15.00M
+15061.3%
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
140
N/A
Net Income
$11.26M
+347.3%
EBITDA
$11.98M
+379.1%
Quarterly Fundamentals
Net Cash
$16.90M
+86.6%
Accounts Receivable
$24.59K
-94.2%
Inventory
$0.00
N/A
Long Term Debt
$19.32K
-89.6%
Short Term Debt
$121.74K
-86.2%
Return on Assets
-10.20%
N/A
Return on Invested Capital
-33.11%
N/A
Free Cash Flow
$11.45M
+334.9%
Operating Cash Flow
$11.45M
+334.9%